Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Malaria vaccine shows 87% efficacy in clinical trial

The novel, genetically attenuated whole-parasite PfSPZ-LARC2 Vaccine for malaria achieved an 87% efficacy rate in preventing infection during a recent phase 1 trial.

Malaria vaccine shows 87% efficacy in clinical trial

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at medicalxpress.com →

More in Health & Medicine

More from Friday 20 November →